BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 1491484)

  • 1. [Protein binding of cephems in the elderly].
    Kuroyama M; Motohashi S; Murase S; Kobayashi T; Tomonaga F; Abe T; Tomita T
    Nihon Ronen Igakkai Zasshi; 1992 Nov; 29(11):874-80. PubMed ID: 1491484
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Protein binding of various cephems in healthy subjects and patients with chronic renal failure].
    Kuroyama M; Kumano K; Tomonaga F; Sakai T; Mashimo S
    Nihon Jinzo Gakkai Shi; 1991 Aug; 33(8):769-77. PubMed ID: 1770637
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Protein binding of oral cephems in patients with chronic renal failure].
    Kuroyama M; Kumano K; Motohashi S; Murase S; Tomonaga F
    Jpn J Antibiot; 1993 Apr; 46(4):323-30. PubMed ID: 8515564
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Comparison of in vitro activity of first, second and third generation cephem antibiotics against various pathogens isolated from clinical materials in 1983].
    Matsuo K; Tsuzaki Y; Furukawa S; Uete T
    Jpn J Antibiot; 1984 Jun; 37(6):1040-57. PubMed ID: 6387213
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Drug-protein binding in elderly subjects].
    Shin K; Katsunuma H
    Nihon Ronen Igakkai Zasshi; 1989 Sep; 26(5):481-8. PubMed ID: 2614998
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Comparison of in vitro activities of first, second and third generation cephem antibiotics against various pathogens isolated from clinical material in 1985].
    Matsuo K; Tsuzaki Y; Furukawa S; Uete T
    Jpn J Antibiot; 1986 Oct; 39(10):2579-86. PubMed ID: 3100836
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Fundamental and clinical studies on cefuzoname in the pediatric field].
    Toyonaga Y; Sugita M; Kawamura K; Seo K; Takahashi T; Hori M
    Jpn J Antibiot; 1987 Apr; 40(4):843-65. PubMed ID: 3613094
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Comparative studies of antimicrobial agents against causative organisms isolated from urinary tract infections (1982). I. Susceptibility distribution].
    Kosakai N; Igari J; Kumamoto Y; Sakai S; Nishio A; Nagai T; Shigeta S; Shiraiwa Y; Abe K; Tazaki H
    Jpn J Antibiot; 1984 Apr; 37(4):680-722. PubMed ID: 6433064
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Salicylate protein binding in serum from young and elderly subjects as measured by diafiltration.
    Lesko LJ; Narang PK; Yeager L; Cutler NR
    Eur J Clin Pharmacol; 1985; 28(3):339-45. PubMed ID: 4007039
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies on protein binding of antibiotics. III. Effect of novobiocin on protein binding and pharmacokinetics of cefoperazone and cefazolin.
    Watanabe Y; Hayashi T; Kitayama R; Yasuda T; Saikawa I; Shimizu K
    J Antibiot (Tokyo); 1981 Jun; 34(6):758-62. PubMed ID: 6456253
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Comparative studies on activities of antimicrobial agents against causative organisms isolated from urinary tract infections (1987). I. Susceptibility distribution].
    Kosakai N; Kumamoto Y; Hirose T; Tanaka N; Hikichi Y; Shigeta S; Shiraiwa Y; Yoshida H; Ogata M; Tazaki H
    Jpn J Antibiot; 1990 Jun; 43(6):919-53. PubMed ID: 2122040
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Antibiotic susceptibility of bacteria isolated from surgical infections (first report)].
    Yura J; Shinagawa N; Ishikawa S; Hayasaka H; Shiramatsu K; Ishibiki K; Aikawa N; Suzuki H; Takahashi T; Sakai K
    Jpn J Antibiot; 1986 Oct; 39(10):2557-78. PubMed ID: 3543430
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Study on the drug sensitivity of multiple drug-resistant Staphylococcus aureus].
    Deguchi K; Fukayama S; Nishimura Y; Yokota N; Tanaka S; Oda S; Matsumoto Y; Ikegami R; Satoh K; Toyonaga Y
    Jpn J Antibiot; 1985 Aug; 38(8):2163-70. PubMed ID: 3852898
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Studies on protein binding of antibiotics. II. Effect of apalcillin on protein binding and pharmacokinetics of cefoperazone and cefazolin.
    Watanabe Y; Hayashi T; Kitayama R; Yasuda T; Saikawa I; Shimizu K
    J Antibiot (Tokyo); 1981 Jun; 34(6):753-7. PubMed ID: 6456252
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [In vitro antibacterial activity of various cephems against clinical isolates from complicated urinary tract infections].
    Kamidono S; Fujii A; Arakawa S; Kataoka N; Ishigami J
    Jpn J Antibiot; 1985 Jan; 38(1):179-89. PubMed ID: 3989977
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Comparison of sensitivity patterns of bacteria isolated from clinical materials to the 2d generation cephamycins and cephalosporins and clinical application of these antibiotics].
    Matsuo K; Uete T
    Jpn J Antibiot; 1983 Jul; 36(7):1621-37. PubMed ID: 6317908
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Comparison of in vitro antibacterial activities of new cephems against clinical organisms (isolated between June 1983 and January 1984)].
    Tsuji A; Goto S; Sato K; Tomizawa M; Hasebe S; Takagi T; Yatagai S; Kanno H; Ozaki K; Yakata M
    Jpn J Antibiot; 1985 Aug; 38(8):2171-84. PubMed ID: 3908734
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Fundamental and clinical studies on cefuzonam in the field of pediatrics].
    Kuno K; Hakamada S; Miyachi Y; Nakashima T; Hayakawa F; Miura K; Miyajima Y
    Jpn J Antibiot; 1987 Feb; 40(2):405-18. PubMed ID: 3599389
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Experimental and clinical evaluation of cefpiramide in pediatrics].
    Toyonaga Y; Kurosu Y; Sugita M; Kawamura G; Ida H; Mochizuki H; Hori M
    Jpn J Antibiot; 1983 Aug; 36(8):2207-27. PubMed ID: 6655842
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of albumin and non-esterified fatty acids on serum prostacyclin binding in pregnancy.
    O'Brien WF; Saba HI; Knuppel RA; Benoit R; Bruce A
    Prostaglandins; 1989 Jan; 37(1):61-7. PubMed ID: 2655012
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.